Drug-induced Immune Thrombocytopenia

References

• Hackett T, Kelton J G, Powers P. Drug-induced platelet destruction. Semin Thromb Hemostas 1982; 8: 116–137
   PubMed Web of Science ®Google Scholar
• Gangarosa E J, Johnson T R, Ramos H S. Ristocetin-induced thrombocytopenia: Site and mechanism of action. Arch Intern Med 1960; 105: 83–89
   PubMedGoogle Scholar
• Karpatkin S. Drug-induced thrombocytopenia. Amer J Med Sci 1971; 262: 68–78
   PubMed Web of Science ®Google Scholar
• Murphy W G, Kelton J G. Idiosyncratic drug-induced thrombocytopenia. Curr Stud Hematol Blood Transf 1988; 54: 71–88
   PubMedGoogle Scholar
• Sinha R K, Kelton J G. Current controversies concerning the measurement of platelet-associated IgG. Transf Med Rev 1990; 4: 121–135
   PubMedGoogle Scholar
• McMillan R. Antigen-specific assays in immune thrombocytopenia. Transf Med Rev 1990; 4: 136–143
   PubMedGoogle Scholar
• Chong B H, Horne S, Berndt M C, Chesterman C N. Studies of the interaction of the quinine/quinidine-dependent antibodies with platelet glycoproteins Ib-IX and IIb-IIIa. Thrombos Haemostas 1989; 62: 46, abstract
   Web of Science ®Google Scholar
• Stricker R B, Shuman M A. Quinidine purpura: evidence that glycoprotein V is a target platelet antigen. Blood 1986; 67: 1377–1381
   PubMed Web of Science ®Google Scholar
• Eisner E V, Shahidi N T. Immune thrombocytopenia due to a drug metabolite. N Engl J Med 1972; 287: 376–381
   PubMed Web of Science ®Google Scholar
• Kiefel V, Santoso S, Schmidt S, et al. Metabolite-specific (IgG) and drug specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion 1987; 27: 262–265
   PubMed Web of Science ®Google Scholar
• Ackroyd J F. The role of complement in sedormid purpura. Clin Sci 1951; 10: 185–205
   PubMed Web of Science ®Google Scholar
• Miescher P A, Miescher A. Die sedormid-anaphylaxie. Schweizerische medizinische Wochenschrift 1952; 82: 1279
   PubMedGoogle Scholar
• Shulman N R. Immunoreactions involving platelets: I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp med 1958; 107: 665–690
   PubMed Web of Science ®Google Scholar
• Landsteiner K. The specificity of serological reactionsrevised ed. Harvard University Press, Cambridge, MA 1947; 185
   Google Scholar
• Green I, Paul W, Benacerraf B. The behaviour of hapten-poly-L-lysine conjugates as a complete antigens in genetic responder and as haptens in nonresponder guinea pigs. J Exp med 1966; 123: 859–879
   PubMed Web of Science ®Google Scholar
• Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: A unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transf Med Rev 1990; 4: 69–77
   PubMedGoogle Scholar
• Anderson C L, Looney R J. Human Leukocyte. IgG Fc receptors. Immunology Today 1986; 7: 264–266
   PubMedGoogle Scholar
• Chong B H, Bendt M C, Koutts J, Castaldi P A. Quinidine-induced thrombocytopenia and leukopenia; demonstration and characterisation of distinct antiplatelet and antileukocyte antibodies. Blood 1983; 62: 1218–1223
   PubMed Web of Science ®Google Scholar
• Christie D J, Mullen P C, Aster R H. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985; 75: 310–314
   PubMed Web of Science ®Google Scholar
• Smith M E, Reid D M, Jones C E, Kautz C A, Shulman N R. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain and is not Fc-dependent. J Clin Invest 1987; 79: 912–917
   PubMed Web of Science ®Google Scholar
• Chong B H. Drug-induced thrombocytopenia: a study of the mechanism of thrombocytopenia caused by heparin and quinidine. Doctoral thesis, University of Sydney, Sydney 1985
   Google Scholar
• Devine D V, Rosse W F. Identification of platelet proteins that bind alloantibodies and autoantibodies. Blood 1984; 64: 1240–1245
   PubMed Web of Science ®Google Scholar
• Christie D J, Mullen P C, Aster R H. Quinine- and quinidine-induced platelet antibodies can react with GPIIb/GPIIIa. Br J Haematol 1987; 67: 213–219
   PubMed Web of Science ®Google Scholar
• Pfuller S L, Bilston R A, Logan D, Gibson J M, Firkin B G. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: Involvement of glycoproteins Ib, IIb, IIIa and IX. Blood 1988; 72: 1155–1162
   PubMed Web of Science ®Google Scholar
• Rosenfeld S I, Looney R J, Leddy J P, Phipps D C, Abrahams G N, Andreson C L. Human platelet Fc receptor for immunoglobulin G. J Clin Invest 1985; 2317–2322
   PubMedGoogle Scholar
• Berndt M C, Gregory C, Kabral A, Zola H, Fournier D, Castaldi P A. Purification and preliminary characterisation of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 1985; 151: 637
   PubMedGoogle Scholar
• Berndt M C, Du X, Booth W J. Ristocetin-dependent reconstruction of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633
   PubMed Web of Science ®Google Scholar
• Kunicki T J, Johnson M M, Aster R H. Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest 1978; 62: 716–719
   PubMed Web of Science ®Google Scholar
• Berndt M C, Gregory C, Chong B H, Zola H, Castaldi P A. Additional glycoprotein defects in Bernard-Soulier's syndrome: confirmation of genetic basis by parental analysis. Blood 1983; 62: 800–807
   PubMed Web of Science ®Google Scholar
• Kunicki T J, Russell N, Nurden A T, Aster R H, Caen J P. Further studies of the human platelet receptor for quinine-and quinidine-dependent antibodies. J Immunol 1981; 126: 398–402
   PubMed Web of Science ®Google Scholar
• Chong B H, Du X, Berndt M C, Horn S, Chesterman C N. Characterisation of the binding domains on platelet glycoproteins Ib-IX and II/IIIa complexes for the quinine/quinine-dependent antibodies. Blood, In Press
   Google Scholar
• van Leeuwen E F, Engelfriet C P, von dem Borne A E G, Kr. Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome. Brit J Haematol 1982; 51: 551–560
   PubMed Web of Science ®Google Scholar
• Lerner W, Caruso R, Faig D, Karpatkin S. Drug-dependent and non-drug dependent antiplatelet antibody drug-induced immunologic thrombocytopenic purpura. Blood 1985; 66: 306–311
   PubMed Web of Science ®Google Scholar
• Szatkowski N S, Kunicki T J, Aster R H. Identification of glycoprotein Ib as a target for antibody in idiopathic (autoimmmune) thrombocytopenic purpura. Blood 1986; 67: 310
   PubMed Web of Science ®Google Scholar
• Chong B H, Berndt M C. Heparin-induced thrombocytopenia. Blut 1989; 58: 53–57
   PubMedGoogle Scholar
• Chong B H. Heparin-induced thrombocytopenia. Blood Reviews 1988; 2: 108–114
   PubMed Web of Science ®Google Scholar
• Bell W R, Royall R M. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980; 303: 902–907
   PubMed Web of Science ®Google Scholar
• Powers P J, Kelton J G, Carter C J. Studies of the frequency of heparin-associated thrombocytopenia. Throm Res 1984; 33: 439–443
   PubMed Web of Science ®Google Scholar
• Green D. Heparin-induced thrombocytopenia. Med J Aust 1986; 144: 37–39, Heparin supplement
   PubMed Web of Science ®Google Scholar
• Heeger P S, Backstrom J T. Heparin flushes and thrombocytopenia (letter). Ann Int Med 1986; 105: 143
   PubMed Web of Science ®Google Scholar
• Chong B H, Pitney W R, Castaldi P A. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982; 2: 1246–1249
   PubMed Web of Science ®Google Scholar
• Ansell J, Deykin D. Heparin-induced thrombocytopenia and recurrent thromboembolism. Am J Haematol 1980; 8: 325–332
   PubMed Web of Science ®Google Scholar
• Kapsch D, Silver D. Heparin-induced thrombocytopenia with thrombosis and haemmorhage. Arch Surg 1981; 116: 1423–1429
   PubMedGoogle Scholar
• Bell W R, Tomasulo P A, Alving B M, Duffy T P. Thrombocytopenia occurring during the administration of heparin 1976; 85: 155–160
   Google Scholar
• Chong B H, Grace C S, Rozenberg M C. Heparin-induced thrombocytopenia: Effect of heparin platelet antibody on platelets. Br J Haematol 1981; 49: 531–540
   PubMed Web of Science ®Google Scholar
• Fratantoni J C, Pollat R, Gralnick H. Heparin-induced thrombocytopenia - Confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395
   PubMed Web of Science ®Google Scholar
• Kelton J G, Meltzer D, Moore J, Giles A R, Wilson W E, Barr R, Hirsch J, Neame P B, Powers P J, Walker I, Bianchi F, Carter C J. Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood 1981; 58: 524–529
   PubMed Web of Science ®Google Scholar
• Kelton J G, Sheridan D, Brian H, Powers P J, Turpie A G, Carter C J. Clinical usefulness of testing for a heparin-dependent platelet aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103: 606–612
   PubMed Web of Science ®Google Scholar
• Sheridan D, Carter C, Kelton J G. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27–30
   PubMed Web of Science ®Google Scholar
• Leroy J, Leelere M H, Delahousse B, Guerois C, Foloppe P, Gruel Y, Toulemonde F. Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216). Semin Throm Hemostas 1985; 11: 326–329
   PubMed Web of Science ®Google Scholar
• Horellon M H, Conard J, Lecrubier C, Samana M, Roque-D'Orbcastelo de Fenoyl O, Di Maria G, Bernadou A. Persistent heparin-induced thrombocytopenia, therapy with low molecular weight heparin. Thromb Haemostas 1984; 51: 134
   PubMed Web of Science ®Google Scholar
• Vitoux J F, Mathieu J F, Roncato M, Fiessinger J N., Aiach M. Heparin-associated thrombocytopenia: treatment with low molecular weight heparin. Thromb Haemostas 1980; 55: 37–39
   Google Scholar
• Roussi J H, Houbouyan L L, Goguel A F. Use of low-molecular weight heparin in heparin induced thrombocytopenia with thrombotic complications. Lancet 1984; 1: 1183
   PubMed Web of Science ®Google Scholar
• Chong B H, Ismail F, Cade J, Gallus A S, Gordon S, Chesterman C N. Heparin-induced thrombocytopenia: Studies with a new low molecular weight heparinoid, Org 10172. Blood 1989; 73: 1592–1596
   PubMed Web of Science ®Google Scholar
• Harenberg J, Zimmermann R, Schwarz F, Kubler W. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid. Lancet 1983; 1: 986–87
   PubMed Web of Science ®Google Scholar
• Chong B H, Castaldi P A. Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia. Aust NZ J Med 1986; 16: 715–716
   PubMedGoogle Scholar
• Salzman E W, Rozenberg R D, Smith M H, Linden J N, Favreau L. Effect of heparin and heparin fractions on platelet aggretation. J Clin Invest 1980; 65: 64–73
   PubMed Web of Science ®Google Scholar
• Chong B H, Ismail F. The mechanism of heparin-induced platelet aggregation. Eur J Haematol 1989; 43: 245–251
   PubMed Web of Science ®Google Scholar
• Mikhailidis D P, Barradas M A, Jeremy J Y, Gracey L, Wakeling A, Dandona P. Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. Eur. J Clin Invest 1985; 15: 313–319
   Web of Science ®Google Scholar
• Lecrubier C, Conrad J, Horellou M H, Khar H, Samana M. Spontaneous platelet aggregation in heparin-treated patients. Acta. Haematologica 1984; 71: 63–65
   Web of Science ®Google Scholar
• Horne M K, Chao E S. Heparin binding to resting and activated platelets. Blood 1989; 74: 238–243
   PubMed Web of Science ®Google Scholar
• Blauhut B, Kramar H, Vinazzer H, Bergmann H. Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 1985; 39: 81–89
   PubMed Web of Science ®Google Scholar
• Nelson J C, Lerner R G, Goldstein R, Cagin N A. Heparin-induced thrombocytopenia. Arch Int Med 1978; 138: 548–552
   PubMed Web of Science ®Google Scholar
• Wahl T O, Lipschitz D A, Stechschulte D J. Thrombocytopenia associated with antiheparin antibody. JAMA 1978; 240: 2560–2562
   PubMed Web of Science ®Google Scholar
• Kelton J G, Powers P J. Heparin-associated thrombocytopenia: An immune disorder. Elsevier, North Holland 1981; 365–375
   Google Scholar
• Trowbridge A A, Caraveo J, Green J B, Amaral B, Stone M J. Heparin-related immune thrombocytopenia. Studies of antibody-heparin specificity. Amer J Med 1978; 65: 277
   PubMed Web of Science ®Google Scholar
• Cines D B, Kaywin P, Bina M, Tomaski A, Schreiber A D. Heparin-associted thrombocytopenia. N Engl J Med 1980; 303: 788–795
   PubMed Web of Science ®Google Scholar
• Cines D B, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 1986; 316: 581–589
   Web of Science ®Google Scholar
• Kelton J G, Sheridan D P, Santos A V, Smith J, Steeves K, Smith C, Brown C, Murphy W G. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988; 72: 925–930
   PubMed Web of Science ®Google Scholar
• Chong B H, Castaldi P A, Berndt M C. Heparin-induced thrombocytopenia: Effects of rabbitt IgG and its Fab and Fc fragments on antibody-heparin-platelet interaction. Thromb Res 1989; 291–295
   PubMed Web of Science ®Google Scholar
• Chong B H, Ismail F, Chesterman C N, Berndt M C. Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematology 1989; 73: 235–240
   PubMed Web of Science ®Google Scholar
• Pfueller S L, David R. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia. Br J Haematology 1986; 64: 149–159
   PubMed Web of Science ®Google Scholar
• Lynch D M, Howe S E. Heparin-associated thrombocytopenia antibody binding specificity to platelet antigens. Blood 1988; 66: 1176–1181
   Google Scholar